147 related articles for article (PubMed ID: 26552734)
1. Germline copy number variation analysis in Finnish families with hereditary prostate cancer.
Laitinen VH; Akinrinade O; Rantapero T; Tammela TL; Wahlfors T; Schleutker J
Prostate; 2016 Feb; 76(3):316-24. PubMed ID: 26552734
[TBL] [Abstract][Full Text] [Related]
2. copy number variation analysis in familial BRCA1/2-negative Finnish breast and ovarian cancer.
Kuusisto KM; Akinrinade O; Vihinen M; Kankuri-Tammilehto M; Laasanen SL; Schleutker J
PLoS One; 2013; 8(8):e71802. PubMed ID: 23967248
[TBL] [Abstract][Full Text] [Related]
3. Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer.
Rökman A; Ikonen T; Seppälä EH; Nupponen N; Autio V; Mononen N; Bailey-Wilson J; Trent J; Carpten J; Matikainen MP; Koivisto PA; Tammela TL; Kallioniemi OP; Schleutker J
Am J Hum Genet; 2002 May; 70(5):1299-304. PubMed ID: 11941539
[TBL] [Abstract][Full Text] [Related]
4. Identification of germline MLH1 alterations in familial prostate cancer.
Fredriksson H; Ikonen T; Autio V; Matikainen MP; Helin HJ; Tammela TL; Koivisto PA; Schleutker J
Eur J Cancer; 2006 Nov; 42(16):2802-6. PubMed ID: 16963262
[TBL] [Abstract][Full Text] [Related]
5. Genetic predisposition to prostate cancer.
Benafif S; Eeles R
Br Med Bull; 2016 Dec; 120(1):75-89. PubMed ID: 27941040
[TBL] [Abstract][Full Text] [Related]
6. Characterization of germline copy number variation in high-risk African American families with prostate cancer.
Ledet EM; Hu X; Sartor O; Rayford W; Li M; Mandal D
Prostate; 2013 May; 73(6):614-23. PubMed ID: 23060098
[TBL] [Abstract][Full Text] [Related]
7. Inherited DNA Repair Gene Mutations in Men with Lethal Prostate Cancer.
Rantapero T; Wahlfors T; Kähler A; Hultman C; Lindberg J; Tammela TL; Nykter M; Schleutker J; Wiklund F
Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32183364
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes.
Kote-Jarai Z; Mikropoulos C; Leongamornlert DA; Dadaev T; Tymrakiewicz M; Saunders EJ; Jones M; Jugurnauth-Little S; Govindasami K; Guy M; Hamdy FC; Donovan JL; Neal DE; Lane JA; Dearnaley D; Wilkinson RA; Sawyer EJ; Morgan A; Antoniou AC; Eeles RA;
Ann Oncol; 2015 Apr; 26(4):756-761. PubMed ID: 25595936
[TBL] [Abstract][Full Text] [Related]
9. Germ-line alterations in MSR1 gene and prostate cancer risk.
Seppälä EH; Ikonen T; Autio V; Rökman A; Mononen N; Matikainen MP; Tammela TL; Schleutker J
Clin Cancer Res; 2003 Nov; 9(14):5252-6. PubMed ID: 14614006
[TBL] [Abstract][Full Text] [Related]
10. Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array.
Saunders EJ; Dadaev T; Leongamornlert DA; Al Olama AA; Benlloch S; Giles GG; Wiklund F; Gronberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Neal D; Pasayan N; Khaw KT; Stanford JL; Blot WJ; Thibodeau SN; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park JY; Kaneva R; Batra J; Teixeira MR; Pandha H; Govindasami K; Muir K; ; ; ; Easton DF; Eeles RA; Kote-Jarai Z
Br J Cancer; 2016 Apr; 114(8):945-52. PubMed ID: 26964030
[TBL] [Abstract][Full Text] [Related]
11. The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer.
Maia S; Cardoso M; Paulo P; Pinheiro M; Pinto P; Santos C; Pinto C; Peixoto A; Henrique R; Teixeira MR
Fam Cancer; 2016 Jan; 15(1):111-21. PubMed ID: 26289772
[TBL] [Abstract][Full Text] [Related]
12. Rare germline genetic variants and risk of aggressive prostate cancer.
Nguyen-Dumont T; MacInnis RJ; Steen JA; Theys D; Tsimiklis H; Hammet F; Mahmoodi M; Pope BJ; Park DJ; Mahmood K; Severi G; Bolton D; Milne RL; Giles GG; Southey MC
Int J Cancer; 2020 Oct; 147(8):2142-2149. PubMed ID: 32338768
[TBL] [Abstract][Full Text] [Related]
13. Association of Inherited Mutations in DNA Repair Genes with Localized Prostate Cancer.
Lee DJ; Hausler R; Le AN; Kelly G; Powers J; Ding J; Feld E; Desai H; Morrison C; Doucette A; Gabriel P; Genetics Center R; Judy RL; Weaver J; Kember R; Damrauer SM; Rader DJ; Domchek SM; Narayan V; Schwartz LE; Maxwell KN
Eur Urol; 2022 Jun; 81(6):559-567. PubMed ID: 34711450
[TBL] [Abstract][Full Text] [Related]
14. ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer.
Rökman A; Ikonen T; Mononen N; Autio V; Matikainen MP; Koivisto PA; Tammela TL; Kallioniemi OP; Schleutker J
Cancer Res; 2001 Aug; 61(16):6038-41. PubMed ID: 11507049
[TBL] [Abstract][Full Text] [Related]
15. Fine mapping of 11q13.5 identifies regions associated with prostate cancer and prostate cancer death.
Nurminen R; Lehtonen R; Auvinen A; Tammela TL; Wahlfors T; Schleutker J
Eur J Cancer; 2013 Oct; 49(15):3335-43. PubMed ID: 23830236
[TBL] [Abstract][Full Text] [Related]
16. Fine-mapping the 2q37 and 17q11.2-q22 loci for novel genes and sequence variants associated with a genetic predisposition to prostate cancer.
Laitinen VH; Rantapero T; Fischer D; Vuorinen EM; Tammela TL; ; Wahlfors T; Schleutker J
Int J Cancer; 2015 May; 136(10):2316-27. PubMed ID: 25335771
[TBL] [Abstract][Full Text] [Related]
17. A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer.
Kote-Jarai Z; Jugurnauth S; Mulholland S; Leongamornlert DA; Guy M; Edwards S; Tymrakiewitcz M; O'Brien L; Hall A; Wilkinson R; Al Olama AA; Morrison J; Muir K; Neal D; Donovan J; Hamdy F; Easton DF; Eeles R; ;
Br J Cancer; 2009 Jan; 100(2):426-30. PubMed ID: 19127258
[TBL] [Abstract][Full Text] [Related]
18. Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease.
Sipeky C; Tammela TLJ; Auvinen A; Schleutker J
Prostate Cancer Prostatic Dis; 2021 Dec; 24(4):1158-1166. PubMed ID: 34012061
[TBL] [Abstract][Full Text] [Related]
19. Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study.
Karlsson Q; Brook MN; Dadaev T; Wakerell S; Saunders EJ; Muir K; Neal DE; Giles GG; MacInnis RJ; Thibodeau SN; McDonnell SK; Cannon-Albright L; Teixeira MR; Paulo P; Cardoso M; Huff C; Li D; Yao Y; Scheet P; Permuth JB; Stanford JL; Dai JY; Ostrander EA; Cussenot O; Cancel-Tassin G; Hoegel J; Herkommer K; Schleutker J; Tammela TLJ; Rathinakannan V; Sipeky C; Wiklund F; Grönberg H; Aly M; Isaacs WB; Dickinson JL; FitzGerald LM; Chua MLK; Nguyen-Dumont T; ; Schaid DJ; Southey MC; Eeles RA; Kote-Jarai Z
Eur Urol Oncol; 2021 Aug; 4(4):570-579. PubMed ID: 33436325
[TBL] [Abstract][Full Text] [Related]
20. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
Jonsson BA; Bergh A; Stattin P; Emmanuelsson M; Grönberg H
Int J Cancer; 2002 Apr; 98(6):838-43. PubMed ID: 11948460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]